AMGN
Price
$298.24
Change
+$1.39 (+0.47%)
Updated
Jul 3 closing price
Capitalization
151.69B
30 days until earnings call
JNJ
Price
$155.56
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
380.22B
10 days until earnings call
Interact to see
Advertisement

AMGN vs JNJ

Header iconAMGN vs JNJ Comparison
Open Charts AMGN vs JNJBanner chart's image
Amgen
Price$298.24
Change+$1.39 (+0.47%)
Volume$1.52M
Capitalization151.69B
Johnson & Johnson
Price$155.56
Change-$0.00 (-0.00%)
Volume$5.41K
Capitalization380.22B
AMGN vs JNJ Comparison Chart in %
Loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGN vs. JNJ commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and JNJ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMGN: $298.24 vs. JNJ: $156.01)
Brand notoriety: AMGN and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 53% vs. JNJ: 46%
Market capitalization -- AMGN: $151.69B vs. JNJ: $380.22B
AMGN [@Pharmaceuticals: Major] is valued at $151.69B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 3 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).

  • AMGN’s FA Score: 3 green, 2 red.
  • JNJ’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than AMGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 8 TA indicator(s) are bullish while JNJ’s TA Score has 6 bullish TA indicator(s).

  • AMGN’s TA Score: 8 bullish, 2 bearish.
  • JNJ’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than JNJ.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +6.85% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +2.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

AMGN is expected to report earnings on Oct 29, 2025.

JNJ is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than AMGN($152B). JNJ has higher P/E ratio than AMGN: JNJ (30.34) vs AMGN (22.66). AMGN YTD gains are higher at: 16.971 vs. JNJ (9.672). JNJ has higher annual earnings (EBITDA): 23.3B vs. AMGN (14.8B). JNJ has more cash in the bank: 22.9B vs. AMGN (10.9B). JNJ has less debt than AMGN: JNJ (29.3B) vs AMGN (64.6B). JNJ has higher revenues than AMGN: JNJ (85.2B) vs AMGN (28.2B).
AMGNJNJAMGN / JNJ
Capitalization152B380B40%
EBITDA14.8B23.3B64%
Gain YTD16.9719.672175%
P/E Ratio22.6630.3475%
Revenue28.2B85.2B33%
Total Cash10.9B22.9B48%
Total Debt64.6B29.3B220%
FUNDAMENTALS RATINGS
AMGN vs JNJ: Fundamental Ratings
AMGN
JNJ
OUTLOOK RATING
1..100
5018
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
3044
SMR RATING
1..100
1333
PRICE GROWTH RATING
1..100
5339
P/E GROWTH RATING
1..100
9279
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (18) in the Pharmaceuticals Major industry is in the same range as AMGN (22) in the Biotechnology industry. This means that JNJ’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's Profit vs Risk Rating (30) in the Biotechnology industry is in the same range as JNJ (44) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to JNJ’s over the last 12 months.

AMGN's SMR Rating (13) in the Biotechnology industry is in the same range as JNJ (33) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as AMGN (53) in the Biotechnology industry. This means that JNJ’s stock grew similarly to AMGN’s over the last 12 months.

JNJ's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as AMGN (92) in the Biotechnology industry. This means that JNJ’s stock grew similarly to AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNJNJ
RSI
ODDS (%)
Bullish Trend 4 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 4 days ago
41%
Momentum
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 4 days ago
41%
MACD
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
41%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 4 days ago
39%
Advances
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 6 days ago
40%
Declines
ODDS (%)
Bearish Trend 10 days ago
52%
Bearish Trend 17 days ago
43%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
44%
Aroon
ODDS (%)
Bullish Trend 4 days ago
45%
Bullish Trend 4 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TOGA34.780.24
+0.70%
Tremblant Global ETF
IDE11.710.02
+0.16%
Voya Infrastructure Industrials AND Materials Fund
ARP28.680.04
+0.14%
PMV Adaptive Risk Parity ETF
STIP102.40-0.08
-0.08%
iShares 0-5 Year TIPS Bond ETF
SPEU48.59-0.04
-0.08%
SPDR® Portfolio Europe ETF

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+0.47%
PFE - AMGN
58%
Loosely correlated
+0.24%
GSK - AMGN
51%
Loosely correlated
-0.86%
GILD - AMGN
49%
Loosely correlated
+0.22%
ABBV - AMGN
48%
Loosely correlated
-0.77%
NVS - AMGN
48%
Loosely correlated
-1.54%
More

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.29%
PFE - JNJ
59%
Loosely correlated
+0.24%
NVS - JNJ
56%
Loosely correlated
-1.54%
GSK - JNJ
52%
Loosely correlated
-0.86%
AMGN - JNJ
43%
Loosely correlated
+0.47%
ABBV - JNJ
43%
Loosely correlated
-0.77%
More